AnalystsInsight

Michael Grondahl (Northland Securities): Analyst Track Record and Price‑Target Accuracy

How often Michael Grondahl’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,682 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#559 rank (was #506)+3 new ratings (HUT, QNST, BULL)

Key takeaways

  • Michael Grondahl ranks #534 of 1,000 analysts in Exent’s scoring (4.8★).
  • 47.5% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 82 days; 54.5% of calls were up 12 months later.
  • Most‑covered stocks: APLD, BTDR, CLSK, WT.
  • Free on Exent: Michael Grondahl’s full record, with ratings 3 days after publication.

Michael Grondahl’s track record at a glance

Michael Grondahl of Northland Securities ranks #534 of the 1,000 analysts Exent scores, with a 4.8★ rating and a focus on financials. Over a 7‑year lookback, 47.5% of Michael’s price targets were reached, 4.9 points below the 52.4% average across all analysts.

MetricMichael GrondahlAll analysts
Price‑target hit rate47.5%52.4%
Median days to hit target82 days91 days
Calls up after 12 months54.5%64.0%
Median 12‑month return of calls+4.9%+13.4%
Hit rate, last 2 years47.7%—
Average worst drop after a call−29.5%—
Ratings in the sample1,682—
Stocks covered59—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetMichael Grondahl
Under 30 days26.7%
30–90 days26.3%
90–180 days23.2%
Over 180 days23.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Michael Grondahl covers most

StockRatings in the sample
APLD41
BTDR26
CLSK23
WT20
ABX19
ECPG17
BULL16
OPFI16

In the past year Michael’s ratings were 97% Buy, 3% Hold and 0% Sell.

Michael Grondahl’s latest ratings

DateStockActionRatingPrice target
Sep 18, 2026HUTReiterated: BuyBuy$120.00
Sep 17, 2026QNSTReiterated: BuyBuy$23.00
Sep 16, 2026BULLReiterated: BuyBuy$15.00
Sep 10, 2026UTIRated: BuyBuy$35.00
Sep 10, 2026WULFReiterated: BuyBuy$30.00
Sep 9, 2026CLSKReiterated: BuyBuy$21.00
Sep 8, 2026WTReiterated: BuyBuy$27.00
Sep 2, 2026BTDRReiterated: BuyBuy$20.00
Sep 1, 2026QNSTReiterated: BuyBuy$21.00
Aug 26, 2026ABXReiterated: BuyBuy$13.50
Aug 24, 2026WULFReiterated: BuyBuy$30.00
Aug 20, 2026APLDReiterated: BuyBuy$82.00
  • Sep 18, 2026
    Stock
    HUT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $120.00
  • Sep 17, 2026
    Stock
    QNST
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $23.00
  • Sep 16, 2026
    Stock
    BULL
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $15.00
  • Sep 10, 2026
    Stock
    UTI
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $35.00
  • Sep 10, 2026
    Stock
    WULF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $30.00
  • Sep 9, 2026
    Stock
    CLSK
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $21.00
  • Sep 8, 2026
    Stock
    WT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $27.00
  • Sep 2, 2026
    Stock
    BTDR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $20.00
  • Sep 1, 2026
    Stock
    QNST
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $21.00
  • Aug 26, 2026
    Stock
    ABX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $13.50
  • Aug 24, 2026
    Stock
    WULF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $30.00
  • Aug 20, 2026
    Stock
    APLD
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $82.00

Michael’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Michael Grondahl’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Michael Grondahl ranks #534 of 1,000 with a 4.8★ rating. 47.5% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 54.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Michael Grondahl’s success rate is 40.7% by the ranking source and 47.5% by Exent’s price-target hit-rate backtest, with a median of 82 days to reach a target.

Michael Grondahl (Northland Securities) covers 59 stocks, mostly in financials. The most frequently rated are APLD, BTDR, CLSK, WT, ABX.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.